Pfizer Investigational Site is a clinical research site located in Seattle, Washington, United States 98101-1448.
Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.
Pfizer Investigational Site has participated in 124 clinical trials.
Therapeutic areas: Osteoporosis, Gastrointestinal Neoplasm, Fibromyalgia.
Sponsors: Ligand Pharmaceuticals, Pfizer, Pfizer's Upjohn has merged with Mylan to form Viatris Inc..
Trust Score: 84/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Pfizer Investigational Site has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Pfizer Investigational Site has 124 clinical trials on record. Their work covers Osteoporosis, Gastrointestinal Neoplasm, Fibromyalgia.
Pfizer Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.